Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RYGB vs Best Medical Treatment for T2DM in Asian Subjects
NCT02041234Phase 4Completed
- Sponsor
- Khoo Teck Puat Hospital
- Start
- Feb 2014
- Primary completion
- Dec 2020
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial (2 arms), sponsored by Khoo Teck Puat Hospital. Primary endpoints: Number of subjects achieving HBA1c of 6% without diabetic medication at 12 months, Number of subjects achieving systolic BP <130mm hg without antihypertension medication at 12 months and 1 more. Started Feb 2014; status: completed.
Beyond the preview
Go deeper on NCT02041234.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02041234.